Arryn Craney
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 5%
- Microbial Metabolism and Applications
Papers in
-
- Biochemical and Structural Characterization 3
-
- SARS-CoV-2 detection and testing 4
- Antimicrobial Resistance in Staphylococcus 4
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Justin R. Nodwell (6 shared papers)Salman Ahmed (2 shared papers)Sheila Marie Pimentel‐Elardo (2 shared papers)Floyd E. Romesberg (8 shared papers)Cory Ozimok (1 shared paper)Alfredo Capretta (1 shared paper)Yihong Li (1 shared paper)Naveen Kumar Navani (1 shared paper)
- Journals
- Journal of Clinical Microbiology (3 papers)mBio (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of Molecular Diagnostics (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Arryn Craney
21 papers receiving 560 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 270
- Biotechnology 94
- Molecular Medicine 45
- Infectious Diseases 126
- Microbiology 28
Countries citing papers authored by Arryn Craney
This map shows the geographic impact of Arryn Craney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arryn Craney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arryn Craney more than expected).
Fields of papers citing papers by Arryn Craney
This network shows the impact of papers produced by Arryn Craney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arryn Craney. The network helps show where Arryn Craney may publish in the future.
Co-authors
The 25 scholars most cited alongside Arryn Craney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 136 | |
| 2 | 2013 | 110 | |
| 3 | 2020 | 65 | |
| 4 | 2007 | 62 | |
| 5 | 2020 | 42 | |
| 6 | 2012 | 25 | |
| 7 | 2015 | 22 | |
| 8 | 2011 | 15 | |
| 9 | 2018 | 15 | |
| 10 | 2015 | 12 | |
| 11 | 2015 | 11 | |
| 12 | 2024 | 11 | |
| 13 | 2016 | 11 | |
| 14 | 2018 | 8 | |
| 15 | 2014 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2017 | 5 | |
| 19 | 2016 | 3 | |
| 20 | 2018 | 2 |
About Arryn Craney
Arryn Craney is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Genetics and Molecular Medicine, having authored 21 papers that have together received 572 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (6 papers), Microbial Natural Products and Biosynthesis (6 papers), Antibiotic Resistance in Bacteria (5 papers), SARS-CoV-2 detection and testing (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Biochemical and Structural Characterization (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Bacteriophages and microbial interactions (3 papers). The work is most often cited by research in Pharmacology (270 citations), Biotechnology (94 citations), Molecular Medicine (45 citations), Infectious Diseases (126 citations) and Microbiology (28 citations). Arryn Craney has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Justin R. Nodwell, Salman Ahmed, Sheila Marie Pimentel‐Elardo, Floyd E. Romesberg, Cory Ozimok, Alfredo Capretta, Yihong Li, Naveen Kumar Navani, Tobias Hohenauer and Hanna Rennert. Their work appears in journals such as Journal of Clinical Microbiology, mBio, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry and Journal of Molecular Diagnostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.